BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 6725522)

  • 1. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
    Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue].
    Utsumi T
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):920-7. PubMed ID: 2796962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies on the formation of estrogens from dehydroepiandrosterone sulfate by human placental microsomes.
    Gibb W; Lavoie JC
    Endocrinology; 1984 Jun; 114(6):2323-9. PubMed ID: 6233132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
    Prost O; Turrel MO; Dahan N; Craveur C; Adessi GL
    Cancer Res; 1984 Feb; 44(2):661-4. PubMed ID: 6581863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.
    Pasqualini JR; Cortes-Prieto J; Chetrite G; Talbi M; Ruiz A
    Int J Cancer; 1997 Mar; 70(6):639-43. PubMed ID: 9096642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase.
    Masamura S; Santner SJ; Santen RJ
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):425-9. PubMed ID: 8903427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.
    James MR; Skaar TC; Lee RY; MacPherson A; Zwiebel JA; Ahluwalia BS; Ampy F; Clarke R
    Endocrinology; 2001 Apr; 142(4):1497-505. PubMed ID: 11250930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
    van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
    J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
    Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
    Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
    González A; Alvarez-García V; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
    Curr Cancer Drug Targets; 2010 May; 10(3):279-86. PubMed ID: 20370689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.